121 related articles for article (PubMed ID: 577481)
1. Radioimmunoassay of the phagocytosis-stimulating peptide tuftsin in normal and splenectomized subjects.
Spirer Z; Zakuth V; Bogair N; Fridkin M
Eur J Immunol; 1977 Feb; 7(2):69-74. PubMed ID: 577481
[No Abstract] [Full Text] [Related]
2. Does tuftsin alter phagocytosis by human polymorphonuclear neutrophils?
Cooper MR; DeChatelet LR; Shirley PS; Cooper MR
Inflammation; 1982 Mar; 6(1):103-12. PubMed ID: 6896319
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of tuftsin, a phagocytosis-stimulating peptide, and its analogs.
Hisatsune K; Kobayashi K; Nozaki S; Muramatsu I
Chem Pharm Bull (Tokyo); 1978 Mar; 26(3):1006-7. PubMed ID: 580599
[No Abstract] [Full Text] [Related]
4. Synthesis and investigation of the biological activity of tuftsin and its analogs.
Konopińska D; Nawrocka E; Siemion TZ; Szymaniec S; Slopek S
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):219-22. PubMed ID: 581929
[No Abstract] [Full Text] [Related]
5. Inhibition by tuftsin of Rauscher virus leukemia development in mice.
Knyszynski A; Gottlieb P; Fridkin M
J Natl Cancer Inst; 1983 Jul; 71(1):87-90. PubMed ID: 6575215
[TBL] [Abstract][Full Text] [Related]
6. Phagocytosis-stimulating activity of tuftsin analogs.
Hisatsune K; Kobayashi K; Nozaki S; Muramatsu I
Microbiol Immunol; 1978; 22(9):581-4. PubMed ID: 581603
[No Abstract] [Full Text] [Related]
7. On the mechanism of action of the phagocytosis-stimulating peptide tuftsin.
Stabinsky Y; Bar-Shavit Z; Fridkin M; Goldman R
Mol Cell Biochem; 1980 Apr; 30(2):71-7. PubMed ID: 6247642
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity of tuftsin.
Martinez J; Winternitz F
Mol Cell Biochem; 1981 Dec; 41():123-36. PubMed ID: 6799777
[TBL] [Abstract][Full Text] [Related]
9. Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes.
Fridkin M; Stabinsky Y; Zakuth V; Spirer Z
Biochim Biophys Acta; 1977 Jan; 496(1):203-11. PubMed ID: 576412
[TBL] [Abstract][Full Text] [Related]
10. Studies of human granulocyte phagocytosis stimulation by tuftsin.
Nishioka K; Wagle JR; Rodriguez T; Maeta M; Kubo S; Dessens SE
J Surg Res; 1994 Jan; 56(1):94-101. PubMed ID: 8277776
[TBL] [Abstract][Full Text] [Related]
11. A new phagocytosis-stimulating tetrapeptide hormone, tuftsin, and its role in disease.
Najjar VA; Constantopoulos A
J Reticuloendothel Soc; 1972 Aug; 12(2):197-215. PubMed ID: 4116440
[No Abstract] [Full Text] [Related]
12. In vitro induction of human granulocyte cytotoxicity by tuftsin.
Nishioka K
Gan; 1979 Dec; 70(6):845-6. PubMed ID: 583412
[No Abstract] [Full Text] [Related]
13. Psychotropic activity of the natural peptide tuftsin.
Valdman AV
Ann Ist Super Sanita; 1982; 18(1):9-12. PubMed ID: 6897809
[No Abstract] [Full Text] [Related]
14. Tuftsin and substance P as modulators of phagocyte functions.
Bar-Shavit Z; Goldman R
Adv Exp Med Biol; 1982; 141():549-58. PubMed ID: 6178274
[No Abstract] [Full Text] [Related]
15. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.
Tzehoval E; Segal S; Stabinsky Y; Fridkin M; Spirer Z; Feldman M
Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3400-4. PubMed ID: 277940
[TBL] [Abstract][Full Text] [Related]
16. Defective phagocytosis due to deficiencies involving the tetrapeptide tuftsin.
Najjar VA
J Pediatr; 1975 Dec; 87(6 Pt 2):1121-4. PubMed ID: 1242395
[TBL] [Abstract][Full Text] [Related]
17. Tuftsin analogs and their biological activity.
Siemion IZ; Konopinska D
Mol Cell Biochem; 1981 Dec; 41():99-112. PubMed ID: 6799778
[No Abstract] [Full Text] [Related]
18. The lack of antigenicity of tuftsin: a naturally occurring phagocytosis stimulating tetrapeptide.
Naim JO; Hinshaw JR; van Oss CJ
Immunol Invest; 1989 Jul; 18(6):817-24. PubMed ID: 2475442
[TBL] [Abstract][Full Text] [Related]
19. [Tuftsin--new analogues and properties].
Wardowska A; Dzierzbicka K; Myśliwski A
Postepy Biochem; 2007; 53(1):60-5. PubMed ID: 17718389
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of the defective monocyte chemotaxis in Hodgkin's disease by in vitro tuftsin treatment.
Lukács K; Berényi E; Kávai M; Szegedi G; Szekerke M
Cancer Immunol Immunother; 1983; 15(2):162-3. PubMed ID: 6553514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
